Bing Center for Waldenstrom's Macroglobulinemia - Publications

You are here: Home

Pub-1997-1998

Latest Bing Center News

Dr. Edward Laane - Running for WM! (Part-2)

Dr. Edward Laane - Running for WM! (Part-2)

On November3, 2019, Dr. Edward Laane ran the Osaka Yodo River Half Marathon, to raise money for Waldenstrom's research. His pure running time was 2.26.07 with his official time listed at 2.31.0. As Dr. Laane recalls, "The run was difficult. It was sunny, and a little bit hot. The first part, 6.5 miles was a little easier. My time was approximately 1h 10 min, but the second part was very difficult. But I was thinking about the patients who have gone through so much treatment and this gave me more strength to finish.

New Approaches to treating Waldenstrom's Macroglobulinemia

New Approaches to treating Waldenstrom's Macroglobulinemia

At the 2019 Lymphoma & Myeloma Congress, Steven Treon, MD, PhD, FACP, FRCP, Harvard University, Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, Massachusetts, provided an update on the latest research in the treatment of Waldenström Macroglobulinemia.

Dr. Edward Laane - Running for WM!

Dr. Edward Laane - Running for WM!

Dr. Edward Laane is running in the Osaka Yodo River Citizens Marathon to raise money for Waldenstrom's research!

IMW-17 Young Investigator Awards

IMW-17 Young Investigator Awards

Congratulations to the following Bing Center researchers for their Young Investigator Awards at the 17th International Workshop on Multiple Myeloma!

IMW-17 Bing Center Poster Presentations

IMW-17 Bing Center Poster Presentations

The 17th International Workshop for Multiple Myeloma was held September 12-15, 2019 at the Hynes Convention Center, Boston, MA, USA. The following are the posters presented by the Bing Center for Waldenstrom's Macroglobulinemia.

17th International Workshop on Multiple Myeloma

17th International Workshop on Multiple Myeloma

The International Myeloma Society's 17th International Myeloma Workshop had record-breaking attendance with more than 3,100 attendees from 61 countries for a successful four days of inspiring education, late-breaking research and spirited discussions with old friends and new.

Dr. Jorge Castillo discusses venetoclax at IMW-17 meeting

Dr. Jorge Castillo discusses venetoclax at IMW-17 meeting

In this video, Dr. Jorge Castillo, clinical director of the Bing Center for WM, discusses the results of a multicenter, phase II study of venetoclax in patients with previously treated WM. This video was created by OncLive during the 17th International Myeloma Workshop in Boston, MA, Sept 12-15, 2019.

Dr. Castillo's Presentation at the 2019 IWMF Ed Forum

Dr. Castillo's Presentation at the 2019 IWMF Ed Forum

Dr. Jorge Castillo's presentation given at the 2019 Ed Forum, June 9, 2019. The Revolution in WM Treatment: What’s on the Horizon

2019 IWMF Ed Forum - Ask the Doctors

2019 IWMF Ed Forum - Ask the Doctors

For those of you who provided questions for the Ask the Doctors session at the IWMF Ed Forum, June 9, 2019, you can now view the entire session online.

2019 IWMF Educational Forum

2019 IWMF Educational Forum

2019 IWMF Educational ForumThe DoubleTree by Hilton Philadelphia Center City – Philadelphia, PAJune 7-9, 2019 The IWMF's annual Educational Forum presents a unique opportunity for patients and caregivers to learn about our disease from world-renowned specialists in Waldenstrom’s macroglobulinemia (WM) who are involved in many areas of clinical practice and research. Held in a different part of the United States every year, the “Ed Forum” offers something for everyone, no matter what your experience or level of knowledge.

Pub-1997-1998

Title
Anti-estrogens induce apoptosis of multiple myeloma cells
Blockade of mitogen-activated protein kinase cascade signaling in interleukin 6-independent multiple myeloma cells
Characterization of p16(INK4A) expression in multiple myeloma and plasma cell leukemia
IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade
Interleukin-6 in multiple myeloma and related plasma cell dyscrasias
Interleukin-6 overcomes p21WAF1 upregulation and G1 growth arrest induced by dexamethasone and interferon-gamma in multiple myeloma cells
MDM2 protein overexpression promotes proliferation and survival of multiple myeloma cells
p16INK4A promotes differentiation and inhibits apoptosis of JKB acute lymphoblastic leukemia cells
Role of CDK4 and p16INK4A in interleukin-6-mediated growth of multiple myeloma
The 86-kD subunit of Ku autoantigen mediates homotypic and heterotypic adhesion of multiple myeloma cells
The development of a model for the homing of multiple myeloma cells to human bone marrow